SVA
Sinovac Biotech Ltd
6.50$
+0.0%
vs. previous close
Closing price · As of: Sep 12, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +7.1% | +7.4% | +140.7% | +31.7% | +7.1% | +107.5% | +3,694.4% | -92.3% | -70.0% | -19.4% | +6.8% | |
| – | +18.9% | +21.6% | -9.6% | +22.1% | +31.3% | +106.9% | +1,496.0% | -36.2% | -73.5% | -22.5% | -11.8% | |
| – | +3.3% | +2.1% | +208.0% | +33.0% | +4.2% | +107.6% | +4,027.4% | -95.6% | -67.0% | -17.3% | +18.7% | |
| – | -13.2% | +33.3% | +62.0% | +6.9% | +10.7% | +101.0% | +218.0% | +185.2% | -22.1% | -21.4% | -20.1% | |
| – | +7.9% | +12.2% | +0.0% | +226.4% | -11.3% | +45.3% | +234.9% | +39.3% | -43.4% | -9.7% | -20.9% | |
| – | -0.5% | +8.3% | +121.5% | +46.8% | -9.3% | +57.3% | +228.8% | +69.6% | -35.9% | +2.8% | -33.9% | |
| – | +96.0% | -86.4% | +8,911.3% | -0.2% | +51.3% | +214.5% | +8,039.9% | -102.7% | – | – | – | |
| – | -43.6% | -9.9% | -9.3% | -31.8% | -39.3% | +123.5% | +95.2% | -55.4% | +78.8% | +149.4% | +74.2% | |
| – | +17.4% | -114.3% | – | +3.4% | +52.0% | +205.9% | +8,007.9% | -99.9% | -706.4% | – | -711.9% | |
| – | +44.3% | -10.8% | +213.0% | +25.6% | -46.5% | +460.9% | +9,773.8% | -102.0% | – | – | – | |
| – | – | – | – | -15.6% | +106.3% | +145.7% | +7,572.0% | -98.7% | -187.8% | – | -165.7% | |
| – | -21.1% | -16.7% | +462.8% | +2.5% | +44.7% | +191.6% | +7,860.2% | -99.0% | -103.3% | – | – |
Data as of: September 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.